Cargando…

Development of MicroRNAs as Potential Therapeutics against Cancer

MicroRNAs (miRNAs) are small noncoding RNAs that function at the posttranscriptional level in the cellular regulation process. miRNA expression exerts vital effects on cell growth such as cell proliferation and survival. In cancers, miRNAs have been shown to initiate carcinogenesis, where overexpres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abd-Aziz, Noraini, Kamaruzman, Nur Izyani, Poh, Chit Laa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378626/ https://www.ncbi.nlm.nih.gov/pubmed/32733559 http://dx.doi.org/10.1155/2020/8029721

Ejemplares similares

Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2019)

Role of microRNAs in antiviral responses to dengue infection
por: Wong, Rui Rui, et al.
Publicado: (2020)

Development of Peptide-Based Vaccines for Cancer
por: Abd-Aziz, Noraini, et al.
Publicado: (2022)

miRNA: A Promising Therapeutic Target in Cancer
por: Menon, Amrutha, et al.
Publicado: (2022)

Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy
por: Tan, Ee Wern, et al.
Publicado: (2022)

siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2018)

The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
por: Khalid, Kanwal, et al.
Publicado: (2023)

The development of DNA vaccines against SARS-CoV-2
por: Khalid, Kanwal, et al.
Publicado: (2023)

Carbonate apatite nanoparticles carry siRNA(s) targeting growth factor receptor genes egfr1 and erbb2 to regress mouse breast tumor
por: Tiash, Snigdha, et al.
Publicado: (2017)

Antivirals blocking entry of enteroviruses and therapeutic potential
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2021)

Targeting Cell Adhesion Molecules via Carbonate Apatite-Mediated Delivery of Specific siRNAs to Breast Cancer Cells In Vitro and In Vivo
por: Ashaie, Maeirah Afzal, et al.
Publicado: (2019)

Development of Novel Vaccines against Enterovirus-71
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2015)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
por: Lim, Hui Xuan, et al.
Publicado: (2019)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
por: Al-Fattah Yahaya, Abdul Aziz, et al.
Publicado: (2023)

Peptides as Therapeutic Agents for Dengue Virus
por: Chew, Miaw-Fang, et al.
Publicado: (2017)

Recent advances in delivery of veterinary DNA vaccines against avian pathogens
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2019)

Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2019)

Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2021)

Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer
por: Inamura, Kentaro
Publicado: (2017)

The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity?
por: Fortunato, Orazio, et al.
Publicado: (2020)

MicroRNAs as potential therapeutic targets for pancreatic cancer
por: Chu, Xiangyu, et al.
Publicado: (2022)

Nanovaccines against Viral Infectious Diseases
por: Heng, Wen Tzuen, et al.
Publicado: (2022)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
por: Lalani, Salima S., et al.
Publicado: (2020)

Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2020)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Antiviral peptides against Enterovirus A71 causing hand, foot and mouth disease
por: Lalani, Salima, et al.
Publicado: (2021)

T Cell Immunity To Enterovirus 71 Infection In Humans And Implications For Vaccine Development
por: Yee, Pinn Tsin Isabel, et al.
Publicado: (2018)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
por: Lee, Michelle Felicia, et al.
Publicado: (2023)

The Potential of MicroRNAs in Personalized Medicine against Cancers
por: Saumet, Anne, et al.
Publicado: (2014)

The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer
por: Mizuno, Rei, et al.
Publicado: (2018)

MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review
por: Ahmed, Jivan Qasim, et al.
Publicado: (2022)

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
por: Jazayeri, Seyed Davoud, et al.
Publicado: (2021)

The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
por: Xu, Xiaona, et al.
Publicado: (2020)

Cardiac microRNAs: diagnostic and therapeutic potential
por: Kabłak-Ziembicka, Anna, et al.
Publicado: (2023)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
por: Lim, Hui Xuan, et al.
Publicado: (2021)

Development of Peptide Vaccines in Dengue
por: Reginald, Kavita, et al.
Publicado: (2018)

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer
por: Yang, Ying, et al.
Publicado: (2022)

microRNAs as Novel Therapeutics in Cancer
por: Romano, Giulia, et al.
Publicado: (2021)

The Conserved Molecular Determinants of Virulence in Dengue Virus
por: Ahmad, Zuleeza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lq14jl4pj7a6f8rbt65q8mtqhk